Delayed Nausea and Vomiting in Patients With Colorectal Cancer Receiving Oxaliplatin
Completed
Conditions studied: Colorectal Cancer, Nausea, Vomiting
In brief
RATIONALE: Learning how often patients experience nausea and vomiting after receiving anti-vomiting medicine and chemotherapy for colorectal cancer may help doctors plan better treatment and improve patients' quality of life. PURPOSE: This clinical trial is studying delayed nausea and vomiting in patients with colorectal cancer receiving standard anti-vomiting medicine during the first course of chemotherapy.
Key facts
- Study ID
- NCT00729677
- Run by
- Beth Israel Medical Center
- People needed
- 64
- Starts
- 2005-06-01
- Expected to finish
- 2008-12-01
- Last updated by the study team
- 2015-10-26
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Beth Israel Medical Center - Philipps Ambulatory Care Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.